Buy OPKWaiting for Cross confirmation for SMA 50 + SMA 200
Current Price is 1.54
Take Profit will be 1.94
Take Profit 2 will be 2.62
Stop Loss below 1
Risk Ratio around 2.2
−0.28USD
−328.405MUSD
1.004BUSD
415.813M
About Opko Health, Inc.
Sector
Industry
CEO
Phillip Frost
Website
Headquarters
Miami
Employees (FY)
4.196K
Founded
1991
ISIN
US68375N1037
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
OPK CatalystFDA approval on Jan 31st so this does have a time frame in which you can pull profits. They are partnered with pfizer on a drug that helps with HGH deficiency in human trials. Currently super low valuation and the fact that this drug will be in the public eye could make this pop. My expectations wil
OPK⬆ BULLISH
Rounding bottom pattern
MktCap 2.4B
Price 3.58
Price target $4.41/ 5.12/ 6.27
Stop loss $3.44
IMO
Back to $4.50, $5.00 in Mid-June (4-HR CHART)Hopefully the $3.50 support holds. Back to ~$4.50 in mid-June perhaps!
Is OPK Fibbin'?OPK back at the .236 fib line, which has been a clear area of support/resistance. The question is, will the speculation on its testing company end up giving the boost needed to push back above the $5 mark or is this truly a "fib" and OPK falls back down heading into the rest of March?
"Ongoing pr
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
